Identifying vancomycin-resistant Enterococcus spp. (VRE) is important so that patients receive appropriate antimicrobial therapy and nosocomial outbreaks can be prevented or controlled. We undertook this study to determine the optimal method for testing the susceptibilities of clinical isolates of Enterococcus spp. to vancomycin in vitro. We compared the performance characteristics of three agar screen plates (Synergy Quad Plate [Remel, Lenexa, Kans.] and two agar screen plates prepared in-house), agar dilution, broth microdilution (Sensititre Just One Strip; AccuMed International, Inc., Westlake, Ohio), the epsilometer test (E test; AB BioDisk, Solna, Sweden), disk diffusion, and the automated Vitek method (bioMerieux, Inc., Hazelwood, Mo.). For all methods, excluding the Synergy Quad Plate and the Vitek methods, two different media, Mueller-Hinton (MH) or brain heart infusion (BHI), were used. Two different incubation periods, 24 and 48 h, were studied for all methods except the Vitek method. For the Vitek method, the gram-positive susceptibility Staphylococcus aureus (GPS-SA) cards, software version R02.03, and a minimum incubation time of 6 h were used.
The susceptibility results for each of the 100 clinical isolates and two reference strains of Enterococcus spp. produced by these methods were interpreted according to 1995 National Committee for Clinical Laboratory Standards (NCCLS) guidelines (6) and compared to the vancomycin resistance genotype. Vancomycin resistance genotypes for each strain were determined by a multiplex PCR method developed in our laboratory (8) to detect the following genes which have been associated with glycopeptide resistance: vanA, vanB, vanC1, vanC2, and vanC3.
(Data from this paper were presented in part at the 96th General Meeting of the American Society for Microbiology, New Orleans, La., 19 to 23 May 1996. [poster C175]) Table 1 , species designations and vancomycin and teicoplanin MICs are shown for the Enterococcus clinical isolates. Species designations for these clinical isolates were previously determined by standard biochemical techniques, and MICs were previously determined by using MH media and an agar dilution technique (8) . For the current study, the test media used, including whether the media were prepared in-house or commercially prepared, inocula, incubation parameters, and susceptibility interpretive guidelines are shown in Table 2 . Except for the commercial methods, available NCCLS guidelines were followed for medium and bacterial inoculum preparation for agar dilution (MH agar) (5), broth microdilution (cation-adjusted MH broth [CAMH broth]) (5) and disk diffusion (MH agar) (4). The results for each method were also interpreted according to NCCLS guidelines (6) . Therefore, the breakpoints used for interpretive categories were the following: susceptible, Յ4 g/ml, intermediate, 8 to 16 g/ml, and resistant, Ն32 g/ml. All Enterococcus isolates were previously surveyed for genes associated with vancomycin resistance by using a multiplex PCR and restriction fragment length polymorphism (RFLP) analysis previously described by us (8) . These results are shown in Table 1 . By this PCR-RFLP method, the vanA, vanB, vanC1, vanC2, and vanC3 genes are identified; however, the vanC2 and vanC3 genes, although amplified, cannot be discriminated from one another. We therefore designate the vanC2 and vanC3 genes vanC-2/3. The susceptibility results for all Enterococcus strains for all methods were compared to the vancomycin genotypes for these strains. Table 3 shows the susceptibility testing results compared to the vancomycin genotype for individual Enterococcus species. There were no growth failures with BHI media. Furthermore, there appeared to be more luxuriant growth with BHI media, making the results easier to interpret. Six strains failed to grow on MH media incubated for either 24 h or 48 h (two with microbroth dilution, one with agar dilution, two with E test, and one with disk diffusion). One growth failure occurred with the Vitek method. For all methods, extension of the incubation time from 24 h to 48 h either produced no difference in the results or gave poorer results. Table 4 summarizes all of the interpretive errors for each method for all of the Enterococcus spp. combined. The following methods produced no very major (resistant strains misinterpreted as susceptible, i.e., false susceptibility) or major (susceptible strains misinterpreted as resistant, i.e., false resistance) interpretive errors when the results were compared to those for the vancomycin resistance genotype: broth microdilution with BHI media incubated for 24 h, agar dilution with BHI media incubated for 24 or 48 h, and E test with BHI media incubated for 24 or 48 h.
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RESULTS
When the results for the two agar screen methods that used BHI media (Synergy Quad Plate or the in-house-prepared BHI agar plate) were compared to the vancomycin resistance genotype, very major errors (Յ2%) occurred only with Enterococcus spp. that carried vanC genes. Unacceptably high frequencies (Ͼ1%) of very major errors occurred when results for disk diffusion with BHI agar or the Vitek method were compared to the vancomycin genotype. Unacceptable frequencies of very major errors (Ͼ1%) occurred with all methods for which MH media were used.
Minor interpretive errors (susceptible or resistant strains misinterpreted as intermediately susceptible) were frequent with all methods. These minor interpretive errors also occurred most frequently with Enterococcus isolates that contained vanC genes which encoded low-level vancomycin resistance (MIC Յ 8 g/ml) as opposed to those isolates which carried the vanA or vanB gene, both of which encoded highlevel vancomycin resistance (MIC Ն 64 g/ml) ( Tables 1  and 4) .
DISCUSSION
Several studies have evaluated the abilities of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in Enterococcus isolates (3, (9) (10) (11) (12) (13) (14) (15) (16) . Those studies which have evaluated current versions of automated or semiautomated commercial systems, such as the Vitek system (bioMerieux, Inc.), the MicroScan Rapid system (Baxter Health Care Corp., West Sacramento, Calif.), or the Alamar MIC system (Alamar Biosciences, Sacramento, Calif.), have shown that these methods do not reliably detect vancomycin resistance in enterococci (11, 13, 15, 16) . Reasons for the poor performance of these systems likely include the composition of growth media and the relatively short incubation times that are used. Most conventional broth-and agar-based manual methods require a full 24 h of incubation, and cur- Vancomycin Teicoplanin
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PCR amplicon produced but with distinct restriction fragment length pattern
a Modified from Table 2 in reference 8.
b Species designations for all clinical isolates were previously determined by standard biochemical techniques, and MICs were determined by an agar dilution technique (8) .
c The multiplex PCR used to determine van genes will not discriminate the vanC-2 gene from the vanC-3 gene (8), which is therefore designated vanC-2/3. d DNA sequencing of the amplicons for the two E. faecalis isolates revealed nucleic acid sequences closely related to the published sequence for the vanB gene (1, 2) . DNA sequencing of the amplicons for the two E. casseliflavus/ flavescens isolates revealed nucleic acid sequences closely related to the published sequences for vanC-2 and vanC-3 genes (7).
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rently, the NCCLS recommends BHI media for the agar screen method (5, 6) . The reliability of the agar screen method for detecting highlevel vancomycin resistance in Enterococcus spp. has been demonstrated. By using 6 g of vancomycin per ml of BHI agar incubated for a full 24 h, Swenson and colleagues (10) demonstrated that this method was 96 to 99% sensitive and 100% specific for the detection of vancomycin resistance among 158 clinical isolates of Enterococcus spp. tested at eight different medical centers. The reliability of other conventional methods for detecting vancomycin resistance in Enterococcus spp., i.e., disk diffusion, agar dilution, and the recently introduced diffusion gradient method, the E test, is less clear (9, 11) . However, problems appear to be most frequent when low-level vancomycin resistance, such as occurs with resistance encoded by the vanC gene group, is encountered. These methods have been studied with MH media as recommended by the NCCLS (4-6) instead of BHI media as recommended by the NCCLS for the agar screen method (5, 6) .
One limitation of all of the above studies may be the inconsistent definition for the "gold standard" or reference susceptibility result. Some investigators have compared test results of the study method to a broth dilution result (11, 13) , while others have compared the results of the study method to results obtained by using either agar dilution (9, 14) , disk diffusion (15), the Micro Scan Rapid method (15, 16) , or E-test method (12) or by comparing results to the vancomycin resistance genotype (3, 10, 11) . Furthermore, for two of these studies, evaluations were limited to Enterococcus isolates with high-level vancomycin resistance (3, 12) .
For the current study, we compared the results of the test methods to the vancomycin resistance genotype. We also compared the performance characteristics of BHI media and the NCCLS-recommended MH media for detection of vancomycin resistance by the agar dilution or disk diffusion method or CAMH media (4-6) by the microbroth dilution method. Furthermore, we evaluated the effects of 24 versus 48 h of incubation.
The results of our study suggest that the optimal phenotypic method for determining vancomycin resistance in Enterococcus spp. is any one of the following: broth dilution with BHI media incubated for 24 h, agar dilution with BHI media incubated for 24 h, or the E test with BHI media incubated for 24 h. Poorer results occurred for all of the methods when MH media were used. In all cases in which the incubation periods were extended to 48 h, either no difference or poorer results were obtained. Both the disk diffusion and Vitek methods produced unacceptably high numbers of very major errors (i.e., exceeding 1.0%). Growth failures did not occur with BHI media for any method. In contrast, six growth failures occurred with MH media incubated for 24 or 48 h (two with microbroth dilution, one with agar dilution, two with E test, and one with disk diffusion). Moreover, the growth of Enterococcus spp. on BHI agar plates (in-house-prepared agar screen plates, agar dilution, E test, and disk diffusion) was more luxuriant and therefore easier to read than MH agar plates.
All of the test methods produced considerable minor errors (minor errors could not be calculated for agar screen plates when results were compared to the vancomycin resistance genotype). These minor errors could be lessened if NCCLS breakpoints for the interpretive categories, susceptible, intermediately susceptible, and resistant, are changed, especially for the Enterococcus spp. with the vanC genes that encode lowerlevel vancomycin resistance. However, the clinical significance of this lower-level resistance remains unknown. One approach might be to identify motile Enterococcus spp. and then apply (27) a Interpretive discrepancies are as follows: very major, resistant strain misinterpreted as susceptible (false-susceptible result); major, susceptible strain misinterpreted as resistant (false-resistant result) (since all E. gallinarium strains carried van resistance genes, they were defined as resistant, and therefore major errors could not exist); minor, resistant or susceptible strain misinterpreted as intermediately susceptible. b The enterococcal strains were incubated for 24 or 48 h, as indicated. For very major interpretive discrepancies, the number of very major errors is shown before the slash, the total number of resistant strains tested (some strains did not grow or were not tested) is shown after the slash, and the percentage of very major errors is shown in parentheses. For major interpretive discrepancies, the number of major errors is shown before the slash, the total number of susceptible strains tested (some strains did not grow or were not tested) is shown after the slash, and the percentage of major errors is shown in parentheses. For minor interpretive discrepancies, the number of minor errors is shown before the slash, the total number of resistant and susceptible strains (some strains did not grow or were not tested) is shown after the slash, and the percentage of intermediate errors is shown in parentheses. NA, not applicable (the agar screen method produces either a resistant or susceptible interpretive result only, so minor interpretive errors cannot be determined). a Interpretive errors are as follows: very major, resistant strain misinterpreted as susceptible (false-susceptible result); major, susceptible strain misinterpreted as resistant (false-resistant result); minor, resistant or susceptible strain misinterpreted as intermediately susceptible. The enterococcal strains were incubated for 24 or 48 h, as indicated, for all methods except Vitek. The number of strains with errors is shown before the slash, the number of strains studied is shown after the slash, and the percentage of strains with errors is shown in parentheses.
b One isolate (E. gallinarum) contained both vanA and vanC-1 genes. Two isolates (E. faecalis) had PCR amplicons with DNA sequences closely related to the vanB gene. Vancomycin MICs for all isolates with vanA or vanB genes were Ն64 g/ml.
c Vancomycin MICs for isolates containing vanC genes ranged from 4 to 8 g/ml. faecalis, yet carried the vanC-1 gene and had low-level resistance (MICs ϭ 8 and 4 g/ml, respectively). Until further clinical information becomes available, we would favor modification of NCCLS breakpoints to resolve this problem. It is generally recommended that "resistant" enterococci that grow on agar screen plates be confirmed by an MIC method (4). The current study demonstrates that two conventional confirmatory MIC methods, broth dilution and agar dilution if used with BHI, and not MH as recommended by the NCCLS, adequately detect vancomycin resistance. In settings where the prevalence of vancomycin resistance is high, we feel the current study demonstrates that it is unnecessary to use the agar screen method when microbroth dilution, agar dilution, and the epsilometer tests are established susceptibility testing methods in the clinical microbiology laboratory and these methods are modified to use BHI media. Furthermore, the current formulation of the agar screen which contains 6 g of vancomycin per ml may not detect low-level resistance vanC genotypes.
